Literature DB >> 16122983

Emergent EEG is helpful in neurology critical care practice.

S Firosh Khan1, R Ashalatha, S V Thomas, P S Sarma.   

Abstract

OBJECTIVE: Emergent EEG (eEEG) is increasingly used in critical care practice related to neurological disorders although it involves considerable reorganization in the neurophysiology department at high cost. There is little data regarding the usefulness of eEEG in acute care situations. Our objective was to audit the practice and utility of eEEG in critical care practice in a developing country.
METHODS: This study was carried out in a tertiary care neurological center situated in a developing country. We had defined eEEG as any EEG performed on a non-elective basis upon request from a clinician for a seemingly emergency indication. All eEEGs performed in the neurophysiology service between October 2002 and September 2003 were reviewed. Referral diagnosis, delay in execution, final diagnosis and outcome were analyzed. eEEG was classified as useful if it clinched a diagnosis, excluded a specific diagnosis or helped in management. Statistical analysis was performed using the chi2 test or Fisher's exact test when indicated. The referral diagnosis and eEEG characteristics were correlated with the utility of the eEEG. Those with P-value <0.05 were considered significant.
RESULTS: There were 286 eEEGs (males 160, mean age 40.6 +/- 23.5 years) among 2798 EEGs (10.2%) performed in the service. eEEG was performed within 24 h in 241 instances and the mean interval from request to formal reporting was 1.13 days. In 62.1% instances eEEG was classified as useful. Usefulness varied according to the referral diagnosis: status epilepticus (n = 41, 100% useful; P = 0.000), brain death (n = 28, 100% useful; P = 0.000), nonconvulsive status (n = 54, 96.3% useful; P = 0.000), recurrent seizures (n = 42, 81% useful; P = 0.006), hypoxic encephalopathy (n = 36, 80.6% useful; P = 0.016), encephalitis (n = 63, 42.9% useful; P = 0.001), metabolic encephalopathy (n=64, 37.4% useful; P = 0.000) and acute demyelination (n = 20, 25% useful; P = 0.001). eEEG findings included epileptiform discharges (n=58), periodic lateralized epileptiform discharges (n=27), discrete seizures (n = 28), nonconvulsive status (n = 12), status epilepticus (n = 8), triphasic waves (n = 15), generalized suppression (n = 22), burst suppression (n = 9), alpha-theta coma (n = 7), electro cerebral silence (n = 2), focal and generalized slowing (n = 172), focal and generalized nonspecific dysfunction (n = 87), and no abnormalities (n = 24). Only discrete seizures (P = 0.000), nonconvulsive status (P = 0.004), generalized suppression (P = 0.004) epileptiform discharges (P = 0.047), and alpha-theta coma pattern (P = 0.047) were significantly correlated with usefulness.
CONCLUSIONS: eEEG provided data that influenced clinical decision-making in the setting of epilepsy related situations, hypoxic encephalopathy and brain death examination. SIGNIFICANCE: eEEG can provide useful information in selected clinical situations in neurological critical care. The service needs to be called upon judiciously in order to improve the efficacy of this service.

Entities:  

Mesh:

Year:  2005        PMID: 16122983     DOI: 10.1016/j.clinph.2005.06.024

Source DB:  PubMed          Journal:  Clin Neurophysiol        ISSN: 1388-2457            Impact factor:   3.708


  12 in total

1.  Electroencephalographic findings in consecutive emergency department patients with altered mental status: a preliminary report.

Authors:  Shahriar Zehtabchi; Samah G Abdel Baki; Arthur C Grant
Journal:  Eur J Emerg Med       Date:  2013-04       Impact factor: 2.799

Review 2.  Recommendations on the use of EEG monitoring in critically ill patients: consensus statement from the neurointensive care section of the ESICM.

Authors:  Jan Claassen; Fabio S Taccone; Peter Horn; Martin Holtkamp; Nino Stocchetti; Mauro Oddo
Journal:  Intensive Care Med       Date:  2013-05-08       Impact factor: 17.440

Review 3.  Nonconvulsive seizures in patients presenting with altered mental status: an evidence-based review.

Authors:  Shahriar Zehtabchi; Samah G Abdel Baki; Shweta Malhotra; Arthur C Grant
Journal:  Epilepsy Behav       Date:  2011-07-23       Impact factor: 2.937

4.  Design of a Wireless EEG System for Point-of-Care Applications.

Authors:  Wenyan Jia; Yicheng Bai; Mingui Sun; Robert J Sclabassi
Journal:  Proc IEEE Annu Northeast Bioeng Conf       Date:  2013-04

Review 5.  Electroencephalographic monitoring in the pediatric intensive care unit.

Authors:  Nicholas S Abend; Kevin E Chapman; William B Gallentine; Joshua Goldstein; Ann E Hyslop; Tobias Loddenkemper; Kendall B Nash; James J Riviello; Cecil D Hahn
Journal:  Curr Neurol Neurosci Rep       Date:  2013-03       Impact factor: 5.081

6.  Non-convulsive status epilepticus and non-convulsive seizures in neurological ICU patients.

Authors:  Ikuko Laccheo; Hasan Sonmezturk; Amar B Bhatt; Luke Tomycz; Yaping Shi; Marianna Ringel; Gina DiCarlo; DeAngelo Harris; John Barwise; Bassel Abou-Khalil; Kevin F Haas
Journal:  Neurocrit Care       Date:  2015-04       Impact factor: 3.210

7.  Effect of microEEG on clinical management and outcomes of emergency department patients with altered mental status: a randomized controlled trial.

Authors:  Shahriar Zehtabchi; Samah G Abdel Baki; Ahmet Omurtag; Richard Sinert; Geetha Chari; Gholamreza S Roodsari; Jeremy Weedon; André A Fenton; Arthur C Grant
Journal:  Acad Emerg Med       Date:  2014-03       Impact factor: 3.451

8.  The new wave: time to bring EEG to the emergency department.

Authors:  Samah G Abdel Baki; Ahmet Omurtag; André A Fenton; Shahriar Zehtabchi
Journal:  Int J Emerg Med       Date:  2011-06-24

9.  Quantitative Infrared Pupillometry in Nonconvulsive Status Epilepticus.

Authors:  Jana Godau; Claudia Bierwirth; Johannes Rösche; Julian Bösel
Journal:  Neurocrit Care       Date:  2020-11-20       Impact factor: 3.210

Review 10.  Electrophysiologic monitoring in acute brain injury.

Authors:  Jan Claassen; Paul Vespa
Journal:  Neurocrit Care       Date:  2014-12       Impact factor: 3.210

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.